Drug
Tak 755
Tak 755: highest development phase Phase 3, developed by Takeda. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| TAK-755 NCT04683003 | Phase 3 | Thrombotic Thrombocytopenic Purpura (TTP) |
Latest
No recent events.
Follow Tak 755 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.